NCT07273643
- Conditions
- Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
- Locations
-
- CHU de Montpellier Montpellier, France
Clinical trial condition
ELGAN (22-28SA)
Explore clinical trials studying ELGAN (22-28SA). Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
ELGAN (22-28SA) trial results
Not Yet Recruiting
Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants
NCT07058025
- Conditions
- Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia (BPD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
- Locations
-
- Royal Alexandra Hospital/Stollery Children's Hospital Edmonton, Alberta, Canada
- McMaster Children's Hospital Hamilton, Ontario, Canada
- The Ottawa Hospital Ottawa, Ontario, Canada
- Sunnybrook Health Sciences Ctr Toronto, Ontario, Canada
Not Yet Recruiting
Cardiovascular Immaturity in Extremely Low Gestational Age Newborns: a Fundamental Prospective Study
NCT06737965
- Conditions
- Cardiovascular Immaturity, ELGAN (22-28SA), Extremely Low Gestational Age Newborns
- Locations
-
- CHU Montpellier Montpellier, France